Acquired vWD in ET — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — D-dimer
In MPN patients with extreme thrombocytosis (>1,000 × 10⁹/L), acquired von Willebrand disease (AvWD) can occur due to adsorption and proteolysis of high-molecular-weight vWF multimers by the excess platelets. This paradoxically causes a BLEEDING phenotype despite thrombocytosis. Testing vWF antigen and ristocetin cofactor activity (which measures vWF function) confirms the diagnosis. Aspirin should be WITHHELD until vWF normalises. Cytoreduction (hydroxyurea) to lower the platelet count restores vWF levels.
Reference: eTG – 2025 – Haematology; EHA – 2022 – MPN Guidelines